Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> Lipopolysaccharide

The macrolide erythromycin (ERM) inhibits excessive neutrophil accumulation and bone resorption in inflammatory tissues. We previously reported that the expression of developmental endothelial locus-1 (DEL-1), an endogenous anti-inflammatory factor induced by ERM, is involved in ERM action. Furtherm...

Full description

Bibliographic Details
Main Authors: Hikaru Tamura, Tomoki Maekawa, Hisanori Domon, Kridtapat Sirisereephap, Toshihito Isono, Satoru Hirayama, Takumi Hiyoshi, Karin Sasagawa, Fumio Takizawa, Takeyasu Maeda, Yutaka Terao, Koichi Tabeta
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/2/303
_version_ 1827756031474663424
author Hikaru Tamura
Tomoki Maekawa
Hisanori Domon
Kridtapat Sirisereephap
Toshihito Isono
Satoru Hirayama
Takumi Hiyoshi
Karin Sasagawa
Fumio Takizawa
Takeyasu Maeda
Yutaka Terao
Koichi Tabeta
author_facet Hikaru Tamura
Tomoki Maekawa
Hisanori Domon
Kridtapat Sirisereephap
Toshihito Isono
Satoru Hirayama
Takumi Hiyoshi
Karin Sasagawa
Fumio Takizawa
Takeyasu Maeda
Yutaka Terao
Koichi Tabeta
author_sort Hikaru Tamura
collection DOAJ
description The macrolide erythromycin (ERM) inhibits excessive neutrophil accumulation and bone resorption in inflammatory tissues. We previously reported that the expression of developmental endothelial locus-1 (DEL-1), an endogenous anti-inflammatory factor induced by ERM, is involved in ERM action. Furthermore, DEL-1 is involved in the induction of bone regeneration. Therefore, in this study, we investigated whether ERM exerts an osteoblastogenic effect by upregulating DEL-1 under inflammatory conditions. We performed in vitro cell-based mechanistic analyses and used a model of <i>Porphyromonas gingivalis</i> lipopolysaccharide (LPS)-induced periodontitis to evaluate how ERM restores osteoblast activity. In vitro, <i>P. gingivalis</i> LPS stimulation suppressed osteoblast differentiation and bone formation. However, ERM treatment combined with <i>P. gingivalis</i> LPS stimulation upregulated osteoblast differentiation-related factors and <i>Del1</i>, indicating that osteoblast differentiation was restored. Alveolar bone resorption and gene expression were evaluated in a periodontitis model, and the results confirmed that ERM treatment increased DEL-1 expression and suppressed bone loss by increasing the expression of osteoblast-associated factors. In conclusion, ERM restores bone metabolism homeostasis in inflammatory environments possibly via the induction of DEL-1.
first_indexed 2024-03-11T08:18:26Z
format Article
id doaj.art-eb3da03291af4e20b0ae1cb1bcca8b3e
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-11T08:18:26Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-eb3da03291af4e20b0ae1cb1bcca8b3e2023-11-16T22:37:47ZengMDPI AGPharmaceuticals1424-82472023-02-0116230310.3390/ph16020303Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> LipopolysaccharideHikaru Tamura0Tomoki Maekawa1Hisanori Domon2Kridtapat Sirisereephap3Toshihito Isono4Satoru Hirayama5Takumi Hiyoshi6Karin Sasagawa7Fumio Takizawa8Takeyasu Maeda9Yutaka Terao10Koichi Tabeta11Division of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Periodontology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanCenter for Advanced Oral Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Microbiology and Infectious Diseases, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanDivision of Periodontology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, JapanThe macrolide erythromycin (ERM) inhibits excessive neutrophil accumulation and bone resorption in inflammatory tissues. We previously reported that the expression of developmental endothelial locus-1 (DEL-1), an endogenous anti-inflammatory factor induced by ERM, is involved in ERM action. Furthermore, DEL-1 is involved in the induction of bone regeneration. Therefore, in this study, we investigated whether ERM exerts an osteoblastogenic effect by upregulating DEL-1 under inflammatory conditions. We performed in vitro cell-based mechanistic analyses and used a model of <i>Porphyromonas gingivalis</i> lipopolysaccharide (LPS)-induced periodontitis to evaluate how ERM restores osteoblast activity. In vitro, <i>P. gingivalis</i> LPS stimulation suppressed osteoblast differentiation and bone formation. However, ERM treatment combined with <i>P. gingivalis</i> LPS stimulation upregulated osteoblast differentiation-related factors and <i>Del1</i>, indicating that osteoblast differentiation was restored. Alveolar bone resorption and gene expression were evaluated in a periodontitis model, and the results confirmed that ERM treatment increased DEL-1 expression and suppressed bone loss by increasing the expression of osteoblast-associated factors. In conclusion, ERM restores bone metabolism homeostasis in inflammatory environments possibly via the induction of DEL-1.https://www.mdpi.com/1424-8247/16/2/303macrolidesperiodontitis<i>Porphyromonas gingivalis</i> lipopolysaccharideosteoblastogenesisdevelopmental endothelial locus-1
spellingShingle Hikaru Tamura
Tomoki Maekawa
Hisanori Domon
Kridtapat Sirisereephap
Toshihito Isono
Satoru Hirayama
Takumi Hiyoshi
Karin Sasagawa
Fumio Takizawa
Takeyasu Maeda
Yutaka Terao
Koichi Tabeta
Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> Lipopolysaccharide
Pharmaceuticals
macrolides
periodontitis
<i>Porphyromonas gingivalis</i> lipopolysaccharide
osteoblastogenesis
developmental endothelial locus-1
title Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> Lipopolysaccharide
title_full Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> Lipopolysaccharide
title_fullStr Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> Lipopolysaccharide
title_full_unstemmed Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> Lipopolysaccharide
title_short Erythromycin Restores Osteoblast Differentiation and Osteogenesis Suppressed by <i>Porphyromonas gingivalis</i> Lipopolysaccharide
title_sort erythromycin restores osteoblast differentiation and osteogenesis suppressed by i porphyromonas gingivalis i lipopolysaccharide
topic macrolides
periodontitis
<i>Porphyromonas gingivalis</i> lipopolysaccharide
osteoblastogenesis
developmental endothelial locus-1
url https://www.mdpi.com/1424-8247/16/2/303
work_keys_str_mv AT hikarutamura erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT tomokimaekawa erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT hisanoridomon erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT kridtapatsirisereephap erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT toshihitoisono erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT satoruhirayama erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT takumihiyoshi erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT karinsasagawa erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT fumiotakizawa erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT takeyasumaeda erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT yutakaterao erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide
AT koichitabeta erythromycinrestoresosteoblastdifferentiationandosteogenesissuppressedbyiporphyromonasgingivalisilipopolysaccharide